GLP1R and type 2 diabetes mellitus: GLP-1 receptor agonists (liraglutide, albiglutide, exenatide long-acting release, or exenatide26, 27, 28, 29, 30), have favorable weight profiles in patients with type 2 diabetes mellitus.